Acute respiratory infection is a significant cause of morbidity and mortality in young, geriatric and immunocompromised patients. Co-infection is also high within these populations and access to advanced technology is essential to detect multiple pathogens at once. False negative test results can lead to a delayed diagnosis and poor clinical outcomes.

Innovative Gx Laboratories’ Respiratory Pathogen Panel (RPP) is a molecular diagnostic test that will rapidly identify a wide range of respiratory pathogens using both Polymerase Chain Reaction (PCR) and Reverse Transcription Polymerase Chain Reaction (RT PCR). Both PCR and RT-PCR technologies precisely identify the correct pathogen(s) present in the infection and will also detect antibiotic drug resistance contained in the pathogen.

• Provides a more definitive diagnosis than point-of-care antigen assays
• 24-hour turnaround from specimen receipt
• More accurate, without the wait times of conventional culture
• CAP accredited/CLIA certified laboratory

Helps improve clinical confidence and decrease patient risks

• Detects polymicrobial infections
• Unaffected by concurrent antibiotic use
• Identifies potential antibiotic resistance
• Aids in quick clinical decision-making
• Reduces false negative results
• Aids in antibiotic stewardship
• Reduces potential unnecessary drug exposure and adverse events